Mediar Therapeutics

Developer of antibody-based therapeutics for treating fibrosis

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 groups2 employees language mediartx.com

Registered entities

Social engagement

Social engagement: 5.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include Ono Venture Investment, Pfizer Ventures, Novartis Venture Fund, Sofinnova Partners.

Investor typeCountShare
Venture capital1158%
Private equity15%
Accelerator & incubator15%
Bank & private debt15%
Other / undisclosed526%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

4 Dec 2025 · Clinical Trial Lead (Sr. CTL/ AD) · Boston

Based on job postings tracked across public sources.

Recent activity

16 Jun 2026
Leadership hire
SVP, Head of Clinical Operations
15 Jun 2026
Event
The Extracellular Matrix Pharmacology Congress
Coming soon